The 2011-2012 pilot European Society of Cardiology Sentinel
Registry of Transcatheter Aortic Valve Implantation: 12-month
clinical outcomes

J 2016

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

GILARD, Martine; Michael SCHLÜTER; Thomas M. SNOW; Gianni DALL´ARA; Helene ELTCHANINOFF et al.

Základní údaje

Originální název

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Autoři

Vydání

Eurointervention, Toulouse, Europa edition, 2016, 1774-024X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Francie

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 5.193

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00092745

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

aortic stenosis; registry; survival; transcatheter aortic valve implantation (TAVI)

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 9. 2. 2017 10:16, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4 +/- 7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unelected elderly patients.

Citovat

GILARD, Martine; Michael SCHLÜTER; Thomas M. SNOW; Gianni DALL´ARA; Helene ELTCHANINOFF; Neil MOAT; Javier GOICOLEA; Gian Paolo USSIA; Petr KALA; Peter WENAWESER; Marian ZEMBALA; Georg NICKENIG; Susanna PRICE; Eduardo Alegria BARRERO; Bernard IUNG; Pepe ZAMORANO; Gerhard SCHULER; Roberto CORTI; Ottavio ALFIERI; Bernard PRENDERGAST; Peter LUDMAN; Stephan WINDECKER; Manel SABATE; Adam WITKOWSKI; Haim DANENBERG; Ervin SCHROEDER; Francesco ROMEO; Carlos MACAYA; Geneviève DERUMEAUX; Cécile LAROCHE; Michele PIGHI; Roberta SERDOZ a Carlo Di MARIO. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes. Eurointervention. Toulouse: Europa edition, 2016, roč. 12, č. 1, s. 79-87. ISSN 1774-024X. Dostupné z: https://doi.org/10.4244/EIJV12I1A15.

@article{1367208,
   author = {Gilard, Martine and Schlüter, Michael and Snow, Thomas M. and Dall´Ara, Gianni and Eltchaninoff, Helene and Moat, Neil and Goicolea, Javier and Ussia, Gian Paolo and Kala, Petr and Wenaweser, Peter and Zembala, Marian and Nickenig, Georg and Price, Susanna and Barrero, Eduardo Alegria and Iung, Bernard and Zamorano, Pepe and Schuler, Gerhard and Corti, Roberto and Alfieri, Ottavio and Prendergast, Bernard and Ludman, Peter and Windecker, Stephan and Sabate, Manel and Witkowski, Adam and Danenberg, Haim and Schroeder, Ervin and Romeo, Francesco and Macaya, Carlos and Derumeaux, Geneviève and Laroche, Cécile and Pighi, Michele and Serdoz, Roberta and Mario, Carlo Di},
   article_location = {Toulouse},
   article_number = {1},
   doi = {https://doi.org/10.4244/EIJV12I1A15},
   keywords = {aortic stenosis; registry; survival; transcatheter aortic valve implantation (TAVI)},
   language = {eng},
   issn = {1774-024X},
   journal = {Eurointervention},
   title = {The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes},
   volume = {12},
   year = {2016}
}

TY  - JOUR
ID  - 1367208
AU  - Gilard, Martine - Schlüter, Michael - Snow, Thomas M. - Dall´Ara, Gianni - Eltchaninoff, Helene - Moat, Neil - Goicolea, Javier - Ussia, Gian Paolo - Kala, Petr - Wenaweser, Peter - Zembala, Marian - Nickenig, Georg - Price, Susanna - Barrero, Eduardo Alegria - Iung, Bernard - Zamorano, Pepe - Schuler, Gerhard - Corti, Roberto - Alfieri, Ottavio - Prendergast, Bernard - Ludman, Peter - Windecker, Stephan - Sabate, Manel - Witkowski, Adam - Danenberg, Haim - Schroeder, Ervin - Romeo, Francesco - Macaya, Carlos - Derumeaux, Geneviève - Laroche, Cécile - Pighi, Michele - Serdoz, Roberta - Mario, Carlo Di
PY  - 2016
TI  - The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes
JF  - Eurointervention
VL  - 12
IS  - 1
SP  - 79-87
EP  - 79-87
PB  - Europa edition
SN  - 1774024X
KW  - aortic stenosis
KW  - registry
KW  - survival
KW  - transcatheter aortic valve implantation (TAVI)
N2  - Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4 +/- 7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unelected elderly patients.
ER  -

GILARD, Martine; Michael SCHLÜTER; Thomas M. SNOW; Gianni DALL´ARA; Helene ELTCHANINOFF; Neil MOAT; Javier GOICOLEA; Gian Paolo USSIA; Petr KALA; Peter WENAWESER; Marian ZEMBALA; Georg NICKENIG; Susanna PRICE; Eduardo Alegria BARRERO; Bernard IUNG; Pepe ZAMORANO; Gerhard SCHULER; Roberto CORTI; Ottavio ALFIERI; Bernard PRENDERGAST; Peter LUDMAN; Stephan WINDECKER; Manel SABATE; Adam WITKOWSKI; Haim DANENBERG; Ervin SCHROEDER; Francesco ROMEO; Carlos MACAYA; Geneviève DERUMEAUX; Cécile LAROCHE; Michele PIGHI; Roberta SERDOZ a Carlo Di MARIO. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes. \textit{Eurointervention}. Toulouse: Europa edition, 2016, roč.~12, č.~1, s.~79-87. ISSN~1774-024X. Dostupné z: https://doi.org/10.4244/EIJV12I1A15.

Přehled o publikaci